News

The patent protects the use of IL-17E to treat cancer, including solid tumors such as colon, breast, ovarian, pancreatic and lung cancers in addition to melanoma until 2026.

DM1, which is also known as Steinert disease and the most common form of muscular dystrophy in adults, is a genetic neuromuscular disease characterized by progressive muscle atrophy,

Based on the positive results from phase I, II studies in Japan and phase III studies in abroad, Astellas has applied for the market authorisation in Japan. Astellas

The acquisition value includes Amylin’s debt proceeds and a contractual payment to Eli Lilly & Company, which amounts to nearly $7bn. With the completion of Bristol-Myers Squibb’s acquisition

The TOURMALINE-MM1 study will compare oral MLN9708 plus lenalidomide and dexamethasone to placebo plus lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma. The randomized, double-blind,

The study will assess the safety and efficacy of TMC435 and daclatasvir in combination with or without Ribavirin in chronic genotype-1 hepatitis C infected patients who are treatment-naive

The finance bought 742,001 shares for Rs115.79 per share on NSE. Macquarie Bank and ABN Amro Bank have sold around 366,000 and 355,485 shares respectively for Rs115.71 on

Veletri (epoprostenol) for injection is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Actelion Pharmaceuticals president Shal Jacobovitz said, "Second

The biotechnology company will use CLIA waived Piccolo Xpress instruments in the course of conducting a four-year drug clinical trial. Abaxis chairman and CEO Clint Severson said an